DISCOVERY OF A NEW-TYPE OF SIALIDASE, KDNASE, WHICH SPECIFICALLY HYDROLYZES DEAMINONEURAMINYL (3-DEOXY-D-GLYCERO-D-GALACTO-2-NONULOSONIC ACID) BUT NOT N-ACYLNEURAMINYL LINKAGES
K. Kitajima et al., DISCOVERY OF A NEW-TYPE OF SIALIDASE, KDNASE, WHICH SPECIFICALLY HYDROLYZES DEAMINONEURAMINYL (3-DEOXY-D-GLYCERO-D-GALACTO-2-NONULOSONIC ACID) BUT NOT N-ACYLNEURAMINYL LINKAGES, The Journal of biological chemistry, 269(34), 1994, pp. 21415-21419
The release of 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN, de
aminoneuraminic acid) residues from their alpha-ketosidic linkage is r
equired to determine the structural and functional role of KDN-glycoco
njugates in sources as disparate as trout egg polysialoglycoproteins a
nd human cancers. We report for the first time the isolation and chara
cterization of a novel type of sialidase (KDNase), which specifically
hydrolyzes KDN ketosidic but not N-acylneuraminyl linkages. KDNase act
ivity was assayed using 4-methylumbelliferyl KDN (4-MU-KDN). A KDNase-
producing microorganism was identified as Sphingobacterium multivorum.
The affinity-purified enzyme was designated KDNase SM to denote its o
rigin and that it was free of N-acylneuraminidase, proteolytic, and ot
her glycosidase activities. KDNase SM activity toward 4-MU-KDN was not
inhibited by the N-acylneuraminidase inhibitor, 2,3-dehydro-2-deoxy-N
-acetylneuraminic acid. KDNase SM released free KDN from naturally occ
urring substrates, including (KDN)GM(3), KDN-glycoprotein, which bears
a number of O-linked chains of KDN alpha 2-->3Gal beta 1-->3GalNAc al
pha 1-->3 (KDN alpha 2-->(-->8KDN alpha 2-->)(n)-->6)GalNAc alpha 1-->
, and the biantennary complex-type of N-glycan, KDN alpha 2-->3Gal bet
a 1-->, 4GlcNAc beta 1-->2Man alpha 1--6(KDN alpha 2-->3Gal beta 1-->4
GlcNAc beta 1-->2 Man alpha 1-->3)Man beta 1-->4GlcNAc beta 1-->4GlcNA
c. KDNase SM thus exhibited a broad linkage specificity and was able t
o hydrolyze the KDN residues ketosidically linked alpha 2-->3, alpha 2
-->6, and alpha 2-->8. The enzyme did not release Neu5Ac or Neu5Gc fro
m 4-MU-Neu5Ac, N-acetylneuraminyllactose, colominic acid, or other Sia
(Neu5Ac or Neu5Gc)-containing glycoconjugates.